Drug
Direct oral anticoagulant
Direct oral anticoagulant is a pharmaceutical drug with 4 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
3(75%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
1
25%
Ph phase_3
1
25%
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 1Safety & dosage
1(50.0%)
Phase 3Large-scale testing
1(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
4
all time
Status Distribution
Active(3)
Completed(1)
Detailed Status
Active, not recruiting2
Completed1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
3
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (50.0%)
Phase 31 (50.0%)
Trials by Status
completed125%
recruiting125%
active_not_recruiting250%
Recent Activity
3 active trials
Showing 4 of 4
active_not_recruitingphase_3
Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus
NCT05825573
active_not_recruitingphase_1
Low Molecular Weight Heparin vs Direct Oral Anticoagulant After Bariatric Surgery
NCT06913595
recruiting
Rivaroxaban in Elderly Chinese Venous Thromboembolism Patients
NCT06194617
completed
Periprocedural Direct Oral Anticoagulant Management
NCT03182218
Clinical Trials (4)
Showing 4 of 4 trials
NCT05825573Phase 3
Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus
NCT06913595Phase 1
Low Molecular Weight Heparin vs Direct Oral Anticoagulant After Bariatric Surgery
NCT06194617
Rivaroxaban in Elderly Chinese Venous Thromboembolism Patients
NCT03182218
Periprocedural Direct Oral Anticoagulant Management
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4